Race-based therapeutics

N Engl J Med. 2004 Nov 11;351(20):2035-7. doi: 10.1056/NEJMp048271. Epub 2004 Nov 8.

Author

M Gregg Bloche¹

Affiliation

¹ Georgetown University Law Center, Washington, DC, USA.

PMID: 15533852
DOI: 10.1056/NEJMp048271

No abstract available

Publication types

Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Black People / genetics*
Drug Approval
Drug Combinations
Drug Industry
Drug Therapy, Combination
Enalapril / therapeutic use
Heart Failure / drug therapy
Heart Failure / ethnology*
Humans
Hydralazine / therapeutic use*
Isosorbide Dinitrate / therapeutic use*
Nitric Oxide Donors / therapeutic use*
Patents as Topic
Pharmacogenetics*
United States
United States Food and Drug Administration
Vasodilator Agents / therapeutic use

Substances

Angiotensin-Converting Enzyme Inhibitors
Drug Combinations
Nitric Oxide Donors
Vasodilator Agents
Hydralazine
Enalapril
Isosorbide Dinitrate